Feasibility, Acceptability, and Implementability of I-IMPACT for ILD
NCT: NCT07780201 · NOT_YET_RECRUITING
Brief Summary
This is a single-centre, two-arm randomised controlled feasibility trial comparing I-IMPACT, an asynchronous digital rehabilitation programme, with conventional centre-based pulmonary rehabilitation (usual care) in adults with Interstitial Lung Disease (ILD). The study will be conducted at the University Hospitals of Leicester NHS Trust, and Glenfield Hospital is the central site for participant recruitment, baseline and longitudinal assessments, and delivery of the in-person usual care arm. This is a feasibility study; therefore, the primary outcome is feasibility (recruitment, attrition, adherence, and acceptability), and the secondary outcomes comprise preliminary clinical and safety parameters. Outcomes will be assessed through a mixed-methods approach, involving both ILD patients and staff (healthcare professionals) participants.
Frequently Asked Questions
What is Feasibility, Acceptability, and Implementability of I-IMPACT for ILD?
Feasibility, Acceptability, and Implementability of I-IMPACT for ILD is a clinical trial registered under NCT07780201. Current status: NOT_YET_RECRUITING.
What is the status of NCT07780201?
The current status of NCT07780201 (Feasibility, Acceptability, and Implementability of I-IMPACT for ILD) is: NOT_YET_RECRUITING.
When did Feasibility, Acceptability, and Implementability of I-IMPACT for ILD start?
Feasibility, Acceptability, and Implementability of I-IMPACT for ILD started on 2026-11.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.